{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T06:15:17Z","timestamp":1759385717195,"version":"build-2065373602"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Charged Multivesicular Body Protein 4A (CHMP4A), a member of the ESCRT-III family, plays a pivotal role in membrane remodeling and fission, with emerging evidence underscoring its significance in cancer immunotherapy. The complex pathogenesis and therapeutic resistance characteristic of liver hepatocellular carcinoma (LIHC) present significant challenges in clinical practice. This study investigated the potential involvement of CHMP4A in the progression of LIHC.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods and results<\/jats:title><jats:p>Utilizing a comprehensive pan-cancer analysis with datasets from The Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO), ArrayExpress database and the International Cancer Genome Consortium (ICGC), we evaluated the prognostic significance of CHMP4A, its clinical implications, associated signaling pathways, DNA methylation status, immune cell infiltration, and response to chemotherapy. Bioinformatics analyses, corroborated by immunohistochemical validation, revealed a marked overexpression of CHMP4A in LIHC specimens relative to adjacent normal tissues. Kaplan-Meier survival analyses indicated that this elevated expression pattern was associated with poor patient outcomes. Single-cell transcriptomic analysis had identified NK\/T cells and tumor cells as the predominant cellular sources of CHMP4A within the LIHC microenvironment. Functional studies employing CHMP4A-specific small interfering RNA (siRNA) revealed significant inhibition of malignant phenotypes in LIHC cells, notably affecting proliferation, migration, and invasive capabilities. Mechanistically, the knockdown of CHMP4A led to modulation of the epithelial-mesenchymal transition (EMT), as indicated by the upregulation of E-cadherin and the concurrent downregulation of vimentin and matrix metalloproteinases (MMP-2\/9). A comprehensive analysis of the immune landscape demonstrated significant correlations between CHMP4A expression patterns and various immunological parameters, including immune cell infiltration, expression of checkpoint molecules, tumor mutational burden (TMB), and microsatellite instability (MSI). Notably, the silencing of CHMP4A markedly decreased the expression levels of the TIM3\/LGALS9 immune checkpoint axis in LIHC.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our extensive analyses identified CHMP4A as a critical molecular determinant in the progression of LIHC, which may function through two oncogenic mechanisms: the promotion of tumor cell proliferation and metastatic potential, and immunomodulatory effects associated with the TIM3\/LGALS9 signaling pathway. These findings indicated that CHMP4A might serve as a potential therapeutic target and prognostic biomarker in LIHC.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1682724","type":"journal-article","created":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T05:34:37Z","timestamp":1759383277000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["CHMP4A in hepatocellular carcinoma: exploring its role in tumor progression, immune modulation, and potential link to TIM3 checkpoint"],"prefix":"10.3389","volume":"16","author":[{"given":"Kai","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Song","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shou-jun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing-hua","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke-run","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41575-022-00688-6","article-title":"Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors","volume":"20","author":"Huang","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-023-00884-y","article-title":"RNA modification-mediated mRNA translation regulation in liver cancer: mechanisms and clinical perspectives","volume":"21","author":"Lin","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.03.003","article-title":"Combination immunotherapy for hepatocellular carcinoma","volume":"79","author":"Rimassa","year":"2023","journal-title":"J Hepatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-021-00438-0","article-title":"Advances in immunotherapy for hepatocellular carcinoma","volume":"18","author":"Sangro","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.815575","article-title":"Knowledge mapping of immunotherapy for hepatocellular carcinoma: A bibliometric study","volume":"13","author":"Shen","year":"2022","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2024.101130","article-title":"Immunotherapy for hepatocellular carcinoma","volume":"6","author":"Childs","year":"2024","journal-title":"JHEP Rep"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32740","article-title":"The liver cancer immune microenvironment: Therapeutic implications for hepatocellular carcinoma","volume":"77","author":"Fonne","year":"2023","journal-title":"Hepatology"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22115801","article-title":"Tumor immune microenvironment and immunosuppressive therapy in hepatocellular carcinoma: A review","volume":"22","author":"Oura","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01624-21","article-title":"Roles of ESCRT proteins ALIX and CHMP4A and their interplay with interferon-stimulated gene 15 during tick-borne flavivirus infection","volume":"96","author":"Tran","year":"2022","journal-title":"J Virol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad7611","article-title":"ESCRT III repairs nuclear envelope ruptures during cell migration to limit DNA damage and cell death","volume":"352","author":"Raab","year":"2016","journal-title":"Science"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S350228","article-title":"Multidimensional analysis of CHMP family members in hepatocellular carcinoma","volume":"15","author":"Guo","year":"2022","journal-title":"Int J Gen Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3892\/ijo.2023.5596","article-title":"CHMP3 promotes the progression of hepatocellular carcinoma by inhibiting caspase\u22121\u2212dependent pyroptosis","volume":"64","author":"Zheng","year":"2024","journal-title":"Int J Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2010.09.020","article-title":"High-throughput screening identifies CHMP4A associated with hypoxia-inducible factor 1","volume":"87","author":"Shi","year":"2010","journal-title":"Life Sci"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1186\/1756-6606-4-37","article-title":"ESCRT-III subunits Snf7\u20131 and Snf7\u20132 differentially regulate transmembrane cargos in hESC-derived human neurons","volume":"4","author":"Lee","year":"2011","journal-title":"Mol Brain"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/cas.15844","article-title":"CHMP4A stimulates CD8+ T-lymphocyte infiltration and inhibits breast tumor growth via the LSD1\/IFN\u03b2 axis","volume":"114","author":"Song","year":"2023","journal-title":"Cancer Sci"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/mc.23767","article-title":"Potentially functional variants of CHMP4A and PANX1 in the pyroptosis-related pathway predict survival of patients with non-oropharyngeal head and neck squamous cell carcinoma","volume":"63","author":"Tang","year":"2024","journal-title":"Mol Carcinog"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02183-20","article-title":"Novel role for ESCRT-III component CHMP4C in the integrity of the endocytic network utilized for herpes simplex virus envelopment","volume":"12","author":"Russell","year":"2021","journal-title":"mBio"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-020-0546-8","article-title":"Visualizing and interpreting cancer genomics data via the Xena platform","volume":"38","author":"Goldman","year":"2020","journal-title":"Nat Biotechnol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gks1193","article-title":"NCBI GEO: archive for functional genomics data sets\u2013update","volume":"41","author":"Barrett","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1210-1248","article-title":"Towards a knowledge-based human protein atlas","volume":"28","author":"Uhlen","year":"2010","journal-title":"Nat Biotechnol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btr597","article-title":"MissForest\u2013non-parametric missing value imputation for mixed-type data","volume":"28","author":"Stekhoven","year":"2012","journal-title":"Bioinformatics"},{"key":"B23","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3791\/62528-v","article-title":"Three differential expression analysis methods for RNA sequencing: Limma, EdgeR, DESeq2","author":"Liu","year":"2021","journal-title":"J Vis Exp"},{"key":"B26","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12874-017-0332-6","article-title":"Time-dependent ROC curve analysis in medical research: current methods and applications","volume":"17","author":"Kamarudin","year":"2017","journal-title":"BMC Med Res Methodol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2017.05.002","article-title":"UALCAN: A portal for facilitating tumor subgroup gene expression and survival analyses","volume":"19","author":"Chandrashekar","year":"2017","journal-title":"Neoplasia"},{"key":"B28","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: kyoto encyclopedia of genes and genomes","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky1055","article-title":"The Gene Ontology Resource: 20 years and still GOing strong","volume":"47","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"100141","DOI":"10.1016\/j.xinn.2021.100141","article-title":"clusterProfiler 4.0: A universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation (Camb)"},{"key":"B31","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkab972","article-title":"EWAS Open Platform: integrated data, knowledge and toolkit for epigenome-wide association study","volume":"50","author":"Xiong","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"B33","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13072-019-0316-3","article-title":"The SMART App: an interactive web application for comprehensive DNA methylation analysis and visualization","volume":"12","author":"Li","year":"2019","journal-title":"Epigenet Chromatin"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkac959","article-title":"TISCH2: expanded datasets and new tools for single-cell transcriptome analyses of the tumor microenvironment","volume":"51","author":"Han","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/psp.2013.56","article-title":"Application of ggplot2 to pharmacometric graphics","volume":"2","author":"Ito","year":"2013","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-0716-0327-7_16","article-title":"Immunedeconv: An R Package for Unified Access to Computational Methods for Estimating Immune Cell Fractions from Bulk RNA-Sequencing Data","author":"Sturm","year":""},{"key":"B37","doi-asserted-by":"publisher","first-page":"e43","DOI":"10.1002\/imt2.43","article-title":"Complex heatmap visualization","volume":"1","author":"Gu","year":"2022","journal-title":"Imeta"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0107468","article-title":"pRRophetic: an R package for prediction of clinical chemotherapeutic response from tumor gene expression levels","volume":"9","author":"Geeleher","year":"2014","journal-title":"PloS One"},{"key":"B39","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1242\/jcs.100115","article-title":"E-cadherin-integrin crosstalk in cancer invasion and metastasis","volume":"126","author":"Canel","year":"2013","journal-title":"J Cell Sci"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.02.024","article-title":"EMT: matter of life or death","volume":"164","author":"Gupta","year":"2016","journal-title":"Cell"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.23.5556","article-title":"Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer","volume":"27","author":"Roy","year":"2009","journal-title":"J Clin Oncol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-4658.2007.06230.x","article-title":"Brox, a novel farnesylated Bro1 domain-containing protein that associates with charged multivesicular body protein 4 (CHMP4)","volume":"275","author":"Ichioka","year":"2008","journal-title":"FEBS J"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-019-0433-3","article-title":"Looking past PD-L1: expression of immune checkpoint TIM-3 and its ligand galectin-9 in cervical and vulvar squamous neoplasia","volume":"33","author":"Curley","year":"2020","journal-title":"Mod Pathol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.canlet.2021.04.011","article-title":"The TIM3\/Gal9 signaling pathway: An emerging target for cancer immunotherapy","volume":"510","author":"Kandel","year":"2021","journal-title":"Cancer Lett"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1682724\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T05:34:38Z","timestamp":1759383278000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1682724\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,2]]},"references-count":44,"alternative-id":["10.3389\/fimmu.2025.1682724"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1682724","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,2]]},"article-number":"1682724"}}